Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) FCF Margin: 2013-2018

Historic FCF Margin for Armata Pharmaceuticals (ARMP) over the last 6 years, with Dec 2018 value amounting to 1,064.09%.

  • Armata Pharmaceuticals' FCF Margin rose 1299909.00% to 1,064.09% in Q4 2018 from the same period last year, while for Dec 2018 it was 1,569.24%, marking a year-over-year increase of 961272.00%. This contributed to the annual value of 708.15% for FY2024, which is 362812.00% up from last year.
  • Per Armata Pharmaceuticals' latest filing, its FCF Margin stood at 1,064.09% for Q4 2018, which was up 50.20% from 708.47% recorded in Q3 2018.
  • Armata Pharmaceuticals' 5-year FCF Margin high stood at 2,131.82% for Q2 2018, and its period low was -11,935.00% during Q4 2017.
  • Its 3-year average for FCF Margin is -5,023.27%, with a median of -3,016.04% in 2016.
  • In the last 5 years, Armata Pharmaceuticals' FCF Margin soared by 8,151,650bps in 2014 and then plummeted by 906,928bps in 2016.
  • Armata Pharmaceuticals' FCF Margin (Quarterly) stood at -3,173.27% in 2014, then surged by 132,405bps to -1,849.22% in 2015, then plummeted by 501,896bps to -6,868.18% in 2016, then tumbled by 506,682bps to -11,935.00% in 2017, then soared by 1,299,909bps to 1,064.09% in 2018.
  • Its FCF Margin stands at 1,064.09% for Q4 2018, versus 708.47% for Q3 2018 and 2,131.82% for Q2 2018.